Xlife Sciences financials at a glance

The revenue of Xlife Sciences is reported as 0.00099 billion Switzerland Francs in the fiscal year 2023. The earnings were 2.08 Switzerland Francs per share in 2023, which was 4 higher than 2022. And about -0.00408 billion Switzerland Francs are reported as free cash flow in the financials of Xlife Sciences 2023. No dividends were paid to the shareholders of the Xlife Sciences stock SWX:XLS in the financial year 2023.